The team believes pairing a latency reversing agent,
like Vorinostat, with an antiviral immune therapy, such as a vaccine or an antibody capable of recognizing and clearing the latent cells, will be needed to achieve a cure.
Using cancer drug
vorinostat, Kennedy believes he can boost the one working copy of TCF4 to compensate for the damaged copy —
like turning up the radio when it has one broken speaker.